rs2424932

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006892.4(DNMT3B):​c.*827A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.696 in 228,750 control chromosomes in the GnomAD database, including 57,214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 39691 hom., cov: 30)
Exomes 𝑓: 0.66 ( 17523 hom. )

Consequence

DNMT3B
NM_006892.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.45

Publications

47 publications found
Variant links:
Genes affected
DNMT3B (HGNC:2979): (DNA methyltransferase 3 beta) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq, May 2011]
DNMT3B Gene-Disease associations (from GenCC):
  • immunodeficiency-centromeric instability-facial anomalies syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency-centromeric instability-facial anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 20-32808730-A-G is Benign according to our data. Variant chr20-32808730-A-G is described in ClinVar as Benign. ClinVar VariationId is 338197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.904 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNMT3BNM_006892.4 linkc.*827A>G 3_prime_UTR_variant Exon 23 of 23 ENST00000328111.6 NP_008823.1 Q9UBC3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNMT3BENST00000328111.6 linkc.*827A>G 3_prime_UTR_variant Exon 23 of 23 1 NM_006892.4 ENSP00000328547.2 Q9UBC3-1

Frequencies

GnomAD3 genomes
AF:
0.712
AC:
108001
AN:
151790
Hom.:
39642
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.883
Gnomad AMI
AF:
0.727
Gnomad AMR
AF:
0.724
Gnomad ASJ
AF:
0.615
Gnomad EAS
AF:
0.926
Gnomad SAS
AF:
0.757
Gnomad FIN
AF:
0.644
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.602
Gnomad OTH
AF:
0.686
GnomAD4 exome
AF:
0.664
AC:
51051
AN:
76842
Hom.:
17523
Cov.:
0
AF XY:
0.658
AC XY:
23387
AN XY:
35534
show subpopulations
African (AFR)
AF:
0.885
AC:
3252
AN:
3674
American (AMR)
AF:
0.744
AC:
1740
AN:
2338
Ashkenazi Jewish (ASJ)
AF:
0.617
AC:
3013
AN:
4880
East Asian (EAS)
AF:
0.905
AC:
9848
AN:
10880
South Asian (SAS)
AF:
0.766
AC:
515
AN:
672
European-Finnish (FIN)
AF:
0.625
AC:
50
AN:
80
Middle Eastern (MID)
AF:
0.584
AC:
278
AN:
476
European-Non Finnish (NFE)
AF:
0.593
AC:
28134
AN:
47446
Other (OTH)
AF:
0.660
AC:
4221
AN:
6396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
799
1599
2398
3198
3997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.712
AC:
108107
AN:
151908
Hom.:
39691
Cov.:
30
AF XY:
0.716
AC XY:
53161
AN XY:
74224
show subpopulations
African (AFR)
AF:
0.883
AC:
36605
AN:
41456
American (AMR)
AF:
0.724
AC:
11039
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.615
AC:
2136
AN:
3472
East Asian (EAS)
AF:
0.926
AC:
4774
AN:
5158
South Asian (SAS)
AF:
0.756
AC:
3632
AN:
4806
European-Finnish (FIN)
AF:
0.644
AC:
6787
AN:
10532
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.602
AC:
40865
AN:
67924
Other (OTH)
AF:
0.683
AC:
1441
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1488
2975
4463
5950
7438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.643
Hom.:
110048
Bravo
AF:
0.726
Asia WGS
AF:
0.812
AC:
2821
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency-centromeric instability-facial anomalies syndrome 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.35
DANN
Benign
0.51
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2424932; hg19: chr20-31396536; API